Bio-Plus Safety Pharmacology is a specialty Contract Research Organization which dedicates its expertise and technology to the evaluation of the cardiac safety of new drugs at the early stages of development, by using a validated and highly predictive platform in anaesthetized guinea-pigs .
Bio-Plus Safety Pharmacology stands for reliable, fast and cost-effective solutions for cardiovascular safety screening.
Our ambition is to progress cardiovascular safety pharmacology; and therefore innovation is key to our approach as demonstated by our flagship technologies: BeatEM® and ChallengEM®.
Site |
Badges |
|
Bio-Plus Safety Pharmacology
Antwerpen, Vlaams Gewest,
Belgium
|
|